Notice of General Meeting

Pharma C Investments PLC

08 September 2023

 

8 September 2023

Notice of General Meeting

Pharma C Investments Plc ("Pharma C" or the "Company") announces that, further to the announcement of 23 August 2023, a general meeting of the Company ("GM") will be held at 10am on Wed 27 September 2023 at the offices of Hill Dickinson LLP. Notice will shortly be posted to shareholders and will be available on the Company's website.

The GM was requisitioned by Paul Ryan, a shareholder holding more than 5% of the issued share capital of the Company to consider the following resolutions:

1.            THAT Gavin Hilary Sathianathan be removed as a director of the Company with immediate effect

2.            THAT Paul Ryan be appointed as a director of the Company

3.            THAT Noel Lyons be appointed as a director of the Company

The Board recommends that shareholders vote against all the resolutions and has set out the reasons for this in the shareholder circular.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

The Directors of Pharma C accept responsibility for this announcement.

END

For additional information please contact:

Pharma C Investments

Gavin Sathianathan, Investment Strategy Director

[e-mail]

Novum Securities (AQSE Corporate Adviser)

Tel: [phone]

David Coffman 

 

END